Skip to main content
Log in

Immunological and immunogenetic markers in sporadic Alzheimer’s disease

  • Original Articles
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Background: Common polymorphisms of genes controlling inflammation-modulating cytokines and acute-phase proteins which play important roles in the pathogenesis of Alzheimer’s disease (AD) have been shown to be associated with AD. Aims: The immunological and immunogenetic markers potentially useful for the AD risk evaluation and diagnosis are briefly reviewed. Conclusion: The state-of-the-art of immunological and immunogenetic markers of AD indicates that new tools and strategies are necessary to identify gene products useful as diagnostic tools.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Nussbaum RL, Ellis CE. Alzheimer’s disease and Parkinson’s disease. N Engl J Med 2003; 348: 1356–64.

    Article  PubMed  CAS  Google Scholar 

  2. Consensus report of the working group on: Molecular and biochemical markers of Alzheimer’s disease. Neurobiol Aging 1998; 19: 109–16.

    Google Scholar 

  3. Teunissen CE, de Vente J, Steinbusch HW, et al. Biochemical markers related to Alzheimer’s dementia in serum and cerebrospinal fluid. Neurobiol Aging 2002; 23: 485–508.

    Article  PubMed  CAS  Google Scholar 

  4. in t’Veld BA, Ruitenberg A, Hofman A, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer’s disease. N Engl J Med 2001; 345: 1515–21.

    Article  Google Scholar 

  5. Licastro F, Chiappelli M. Brain immune responses cognitive decline and dementia: relationship with phenotype expression and genetic background. Mech Ageing Dev 2003; 124: 539–48.

    Article  PubMed  CAS  Google Scholar 

  6. Lio D, Licastro F, Scola L, et al. Interleukin-10 promoter polymorphism in sporadic Alzheimer’s disease. Genes Immun 2003; 4: 234–8.

    Article  PubMed  CAS  Google Scholar 

  7. Franceschi C, Valensin S, Lescai F, et al. Neuroinflammation and the genetics of Alzheimer’s disease: The search for a pro-inflammatory phenotype. Aging Clin Exp Res 2001; 13: 163–70.

    CAS  Google Scholar 

  8. Lee YB, Nagai A, Kim SU. Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res 2002; 69: 94–103.

    Article  PubMed  CAS  Google Scholar 

  9. Licastro F, Candore G, Lio D, et al. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing 2005; 2: 8–23.

    Article  PubMed  Google Scholar 

  10. Candore G, Balistreri CR, Colonna-Romano G, Lio D, Caruso C. Major histocompatibility complex and sporadic Alzheimer’s disease: a critical reappraisal. Exp Gerontol 2004; 39: 643–50.

    Article  Google Scholar 

  11. Combarros O, Llorca J, Sanchez-Guerra M, Infante J, Berciano J. Age-dependent association between interleukin-1A (-889) genetic polymorphism and sporadic Alzheimer’s disease. A metaanalysis. J Neurol 2003; 250: 987–9.

    Article  CAS  Google Scholar 

  12. Grimaldi LM, Casadei VM, Ferri C, et al. Association of early-onset Alzheimer’s disease with an interleukin-1alpha gene polymorphism. Ann Neurol 2000; 47: 361–5.

    Article  PubMed  CAS  Google Scholar 

  13. Li R, Yang L, Lindholm K, et al. Tumor necrosis factor death receptor signaling cascade is required for amyloid-beta protein-induced neuron death. J Neurosci 2004; 24: 1760–71.

    Article  PubMed  CAS  Google Scholar 

  14. Uberti D, Cantarella G, Facchetti F, et al. TRAIL is expressed in the brain cells of Alzheimer’s disease patients. Neuroreport 2004; 15: 579–81.

    Article  PubMed  CAS  Google Scholar 

  15. Caruso C, Franceschi C, Licastro F. Genetics of neurodegener-ative disorders. N Engl J Med 2003; 349: 193–4 (Letter).

    Article  PubMed  Google Scholar 

  16. Lio D, Caruso C. IL-10, Genetic polymorphism and its relevance to age-related diseases. In Marincola FM, ed. Interleukin 10. Eurekah.com 2004; 3.4: 1–14.

    Google Scholar 

  17. Caruso C, Candore G, Colonna-Romano G, Lio D, Franceschi C. Inflammation and life-span. Science 2005; 307: 208–9 (Letter).

    Article  PubMed  CAS  Google Scholar 

  18. Neale BM, Sham PC. The future of association studies: gene-based analysis and replication. Am J Hum Genet 2004; 75: 353–62.

    Article  PubMed  CAS  Google Scholar 

  19. Zhang R, Barker L, Pinchev D, et al. Mining biomarkers in human sera using proteomic tools. Proteomics 2004; 4: 244–56.

    Article  PubMed  CAS  Google Scholar 

  20. Cagnin A, Brooks DJ, Kennedy AM, et al. In-vivo measurement of activated microglia in dementia. Lancet 2001; 358: 461–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Domenico Lio.

Additional information

This work was presented at the “International Meeting — The Aging People”, Pavia, 2–4 September 2004.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lio, D., Scola, L., Romano, G.C. et al. Immunological and immunogenetic markers in sporadic Alzheimer’s disease. Aging Clin Exp Res 18, 163–166 (2006). https://doi.org/10.1007/BF03327434

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03327434

Keywords

Navigation